Schonfeld Strategic Advisors’s Loxo Oncology, Inc LOXO Stock Holding History

Schonfeld Strategic Advisors’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-14,300	Closed	-$2M	–	1433
2018 Q4	$2M	Buy	14,300 +4,300	+43%	+$653K	0.08%	327
2018 Q3	$1.71M	Hold	10,000	–	–	0.08%	317
2018 Q2	$1.74M	Buy	+10,000	New	+$1.5M	0.09%	294
2017 Q4	–	Sell	-75,000	Closed	-$6.91M	–	965
2017 Q3	$6.91M	Sell	75,000 -25,000	-25%	-$1.94M	0.63%	35
2017 Q2	$8.02M	Sell	100,000 -47	-0%	-$2.6K	0.83%	15
2017 Q1	$4.21M	Buy	100,047 +53,147	+113%	+$2.19M	0.42%	60
2016 Q4	$1.51M	Buy	+46,900	New	+$1.2M	0.2%	161

Other funds holding LOXO

IUHSA

Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

Schonfeld Strategic Advisors's LOXO Position: Q1 2019 in Review

Schonfeld Strategic Advisors sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 14,300 shares — an estimated $2M sold.

Schonfeld Strategic Advisors first reported a position in LOXO in Q4 2016 and held it in 7 quarters. The position peaked at $8.02M in Q2 2017. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

Schonfeld Strategic Advisors reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
Schonfeld Strategic Advisors sold 14,300 Loxo Oncology, Inc shares in Q1 2019, an estimated $2M.
Schonfeld Strategic Advisors first reported a position in Loxo Oncology, Inc in Q4 2016 and held it in 7 quarters.
Schonfeld Strategic Advisors's Loxo Oncology, Inc position peaked at $8.02M in Q2 2017.
1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2019, filed 15 May 2019.